日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Potassium binders in clinical practice: understanding potassium binder use in contemporary Swedish healthcare-the DEMONSTRATE database

临床实践中的钾结合剂:了解当代瑞典医疗保健中钾结合剂的使用——DEMONSTRATE数据库

Furuland, Hans; Larsson, Anders Olof; Bjellerup, Per; Uhde, Milica; Cars, Thomas; Almstedt, Matilda; Svensson, Maria K

Brain natriuretic peptide and all-cause mortality in patients treated with haemodialysis

脑钠肽与血液透析患者的全因死亡率

Svensson, Maria K; Nassar, Rita; Melin, Jan; Lindberg, Magnus; Furuland, Hans; Stenberg, Jenny

Anaemia and quality of life in chronic kidney disease: a consensus document from the European Anaemia of CKD Alliance

慢性肾脏病贫血与生活质量:欧洲慢性肾脏病贫血联盟共识文件

Dasgupta, Indranil; Bagnis, Corinne Isnard; Floris, Matteo; Furuland, Hans; Zurro, Daniel Gallego; Gesualdo, Loreto; Heirman, Nathalie; Minutolo, Roberto; Pani, Antonello; Portolés, José; Rosenberger, Christian; Alvarez, José Emilio Sánchez; Torres, Pablo Ureña; Vanholder, Raymond C; Wanner, Christoph

A case of enamel renal syndrome from a novel genetic mutation, multidisciplinary management and long-term prognosis

一例由新型基因突变引起的牙釉质肾综合征病例报告、多学科诊疗及长期预后

Erkapers, Maria; Frykholm, Carina; Furuland, Hans; Segerström, Susanna; Thor, Andreas

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial

肾移植受者从钙调神经磷酸酶抑制剂转换为贝拉西普治疗后的心血管风险:一项随机临床试验

Bredewold, Obbo W; Chan, Joe; Svensson, My; Bruchfeld, Annette; de Fijter, Johan W; Furuland, Hans; Grinyo, Josep M; Hartmann, Anders; Holdaas, Hallvard; Hellberg, Olof; Jardine, Alan; Mjörnstedt, Lars; Skov, Karin; Smerud, Knut T; Soveri, Inga; Sørensen, Søren S; Zonneveld, Anton-Jan van; Fellström, Bengt

Cost effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalaemia in patients with CKD in Norway and Sweden

在挪威和瑞典,使用环硅酸锆钠治疗慢性肾病患者高钾血症的成本效益分析

Kim, Kun; Fagerström, Josefine; Chen, Gengshi; Lagunova, Zoya; Furuland, Hans; McEwan, Phil

Effects of spironolactone on extrasystoles and heart rate variability in haemodialysis patients: a randomised crossover trial

螺内酯对血液透析患者期前收缩和心率变异性的影响:一项随机交叉试验

Eklund, Michael; Hellberg, Olof; Furuland, Hans; Cao, Yang; Nilsson, Erik

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics

达格列净预防慢性肾脏病不良结局(DAPA-CKD)试验:基线特征

Wheeler, David C; Stefansson, Bergur V; Batiushin, Mikhail; Bilchenko, Oleksandr; Cherney, David Z I; Chertow, Glenn M; Douthat, Walter; Dwyer, Jamie P; Escudero, Elizabeth; Pecoits-Filho, Roberto; Furuland, Hans; Górriz, José Luis; Greene, Tom; Haller, Hermann; Hou, Fan Fan; Kang, Shin-Wook; Isidto, Rey; Khullar, Dinesh; Mark, Patrick B; McMurray, John J V; Kashihara, Naoki; Nowicki, Michal; Persson, Frederik; Correa-Rotter, Ricardo; Rossing, Peter; Toto, Robert D; Umanath, Kausik; Van Bui, Pham; Wittmann, István; Lindberg, Magnus; Sjöström, C David; Langkilde, Anna Maria; Heerspink, Hiddo J L

Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom

英国一组新发慢性肾病或心力衰竭患者中肾素-血管紧张素-醛固酮系统抑制剂剂量、高钾血症和不良临床结局的真实世界关联

Linde, Cecilia; Bakhai, Ameet; Furuland, Hans; Evans, Marc; McEwan, Phil; Ayoubkhani, Daniel; Qin, Lei

Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK

英国21334例心力衰竭患者血清钾水平与临床结局:风险计算结果

Linde, Cecilia; Qin, Lei; Bakhai, Ameet; Furuland, Hans; Evans, Marc; Ayoubkhani, Daniel; Palaka, Eirini; Bennett, Hayley; McEwan, Phil